Testing effectiveness (Phase 2)Study completedNCT00269412
What this trial is testing
Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome
Who this might be right for
Irritable Bowel Syndrome
Bausch Health Americas, Inc. 525